Evaluation of the Performance of the Cobas CT/NG Test for Use on the Cobas 6800/8800 Systems for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Male and Female Urogenital Samples
暂无分享,去创建一个
E. Marlowe | K. Fife | B. Van Der Pol | R. Arcenas | M. Nye | S. Chavoustie | D. Eisenberg | S. Taylor | L. Crane | Gregory Hirsch
[1] R. Peeling,et al. Systematic reviews of point-of-care tests for the diagnosis of urogenital Chlamydia trachomatis infections , 2017, Sexually Transmitted Infections.
[2] E. Marlowe,et al. High-Throughput Testing of Urogenital and Extragenital Specimens for Detection of Chlamydia Trachomatis and Neisseria Gonorrhoeae with Cobas® CT/NG , 2017, European journal of microbiology & immunology.
[3] L. Katz,et al. The cobas® 6800/8800 System: a new era of automation in molecular diagnostics , 2017, Expert review of molecular diagnostics.
[4] Tracy A Wolff,et al. Sexually Transmitted Infections: Recommendations from the U.S. Preventive Services Task Force. , 2016, American family physician.
[5] M. Smieja,et al. Ease, Comfort, and Performance of the HerSwab Vaginal Self-Sampling Device for the Detection of Chlamydia trachomatis and Neisseria gonorrhoeae , 2016, Sexually transmitted diseases.
[6] J. Klausner,et al. Sexually transmitted infections and pre-exposure prophylaxis: challenges and opportunities among men who have sex with men in the US , 2016, AIDS Research and Therapy.
[7] Marleen Temmerman,et al. Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global Reporting , 2015, PloS one.
[8] C. B. Hare,et al. No New HIV Infections With Increasing Use of HIV Preexposure Prophylaxis in a Clinical Practice Setting. , 2015, Clinical Infectious Diseases.
[9] P. Paudyal,et al. Obtaining Self-Samples to Diagnose Curable Sexually Transmitted Infections: A Systematic Review of Patients’ Experiences , 2015, PloS one.
[10] Megha L Mehrotra,et al. Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study. , 2014, The Lancet. Infectious diseases.
[11] Nathan A. Ledeboer,et al. Point-Counterpoint: The Automated Clinical Microbiology Laboratory: Fact or Fantasy? , 2014, Journal of Clinical Microbiology.
[12] C. Gaydos,et al. Performance of the Cepheid CT/NG Xpert Rapid PCR Test for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae , 2013, Journal of Clinical Microbiology.
[13] E. Hook,et al. Vaginal swabs are the optimal specimen for detection of genital Chlamydia trachomatis or Neisseria gonorrhoeae using the Cobas 4800 CT/NG test. , 2013, Sexually transmitted diseases.
[14] M. Unemo,et al. 2012 European guideline on the diagnosis and treatment of gonorrhoea in adults , 2013, International journal of STD & AIDS.
[15] R. Lillis,et al. Evaluation of the Roche cobas® CT/NG Test for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Male Urine , 2012, Sexually transmitted diseases.
[16] R. Lillis,et al. Performance of the cobas CT/NG Test Compared to the Aptima AC2 and Viper CTQ/GCQ Assays for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae , 2012, Journal of Clinical Microbiology.
[17] David V Glidden,et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. , 2010, The New England journal of medicine.
[18] M. Unemo,et al. 2015 European guideline on the management of Chlamydia trachomatis infections , 2010, International journal of STD & AIDS.
[19] Mario Plebani,et al. The “hospital central laboratory”: automation, integration and clinical usefulness , 2010, Clinical chemistry and laboratory medicine.
[20] N. Holder. Gonococcal infections. , 2008, Pediatrics in review.
[21] G. Pugliese,et al. Severe Streptococcus pyogenes Infections, United Kingdom, 2003–2004 , 2008, Emerging infectious diseases.
[22] Charlotte A. Gaydos,et al. Multicenter Evaluation of the BDProbeTec ET System for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Urine Specimens, Female Endocervical Swabs, and Male Urethral Swabs , 2001, Journal of Clinical Microbiology.
[23] M. R. Howell,et al. Point-of-entry screening for C. trachomatis In female army recruits. Who derives the cost savings? , 2000, American journal of preventive medicine.
[24] R. Knaup,et al. Urine Screening for Gonococcal and Chlamydial Infections at Community‐Based Organizations in a High‐Morbidity Area , 2000, Sexually transmitted diseases.
[25] M. R. Howell,et al. Control of Chlamydia trachomatis infections in female army recruits: cost-effective screening and treatment in training cohorts to prevent pelvic inflammatory disease. , 1999, Sexually transmitted diseases.
[26] D. Fleming,et al. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. , 1999, Sexually transmitted infections.
[27] Charlotte Gaydos,et al. Screening for Chlamydia trachomatis in Asymptomatic Women Attending Family Planning Clinics: A Cost-Effectiveness Analysis of Three Strategies , 1998, Annals of Internal Medicine.
[28] L. Bodin,et al. Decreasing Incidences of Gonorrhea‐ and Chlamydia‐Associated Acute Pelvic Inflammatory Disease: A 25‐Year Study From an Urban Area of Central Sweden , 1996, Sexually transmitted diseases.
[29] M. Unemo,et al. European Guideline for the Management of Chlamydia Trachomatis Infections , 2022 .
[30] C. Bébéar,et al. Genital Chlamydia trachomatis infections. , 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[31] S. Hewitt,et al. HIV prevention through early detection and treatment of other sexually transmitted diseases--United States. Recommendations of the Advisory Committee for HIV and STD prevention. , 1998, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[32] G. Schmid,et al. Recommendations for the Prevention and Management of Chlamydia trachomatis Infections , 1993 , 1994 .